The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
The Thyroid Epidemiology, Audit, and Research Study (TEARS): Morbidity in Patients with Endogenous Subclinical Hyperthyroidism
Abstract
OBJECTIVE: Our objective was to investigate the long-term outcomes for patients with endogenous subclinical hyperthyroidism (SH). DESIGN: Population record-linkage technology was used retrospectively to identify patients with SH and hospital admissions from January 1, 1993, to December 31, 2009. PATIENTS: All Tayside residents over 18 yr old with at least two serum TSH measurements below the reference range for at least 4 months apart and normal free T(4)/total T(4) and normal total T(3) concentrations at baseline were included as potential cases. Using a unique patient identifier, data linkage enabled a cohort of SH cases to be identified from biochemistry, prescription, admission, and radioactive iodine treatment records matched to five comparators from the general population. OUTCOME MEASURES: The association between endogenous SH and cardiovascular disease, fracture, dysrhythmia, dementia, and cancer was assessed. RESULTS: Compared with the reference population, SH was associated with an increased risk of nonfatal cardiovascular morbidity, osteoporotic fracture, dysrhythmia, and dementia, with adjusted hazard ratios (HR) of 1.39 (1.22-1.58), 1.25 (1.04-1.50), 1.65 (1.26-2.17), and 1.64 (1.20-2.25), respectively. When SH patients who developed overt hyperthyroidism during follow-up were excluded, SH patients were associated with an increased risk of cardiovascular morbidity [HR = 1.36 (1.19-1.57)], dysrhythmia [HR = 1.39 (1.02-1.90)], and dementia [HR = 1.79 (1.28-2.51)] but not fracture and cancer. CONCLUSION: Patients with endogenous SH have an increased risk of cardiovascular disease and dysrhythmia. There is an association with fracture and dementia that is not related to TSH concentration and therefore is less likely to be causally related. No association was found between SH and cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In TEARS, SHyper was associated with an increased risk of fractures that was not related to TSH concentration [63] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [63]
In the citing paper
“Conflicting results have also been reported regarding the risk of fractures [63,105,106] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [63]
In the citing paper
“The risk of dementia, although increased in Endo SHyper, was not related to TSH concentration in the Thyroid Epidemiology, Audit and Research Study (TEARS), suggesting that it was not causally related [63] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [63]
In the citing paper
“Similarly, in a large retrospective case-control study, which was not included in the metaanalysis by Collet et al., an association between SHyper and increased risk of arrhythmia was reported in patients with grade 2 SHyper [63] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [63]
In the citing paper
“Some of these studies, including the meta-analyses, have also examined nonfatal cardiovascular events in SH, with similar increased risks (383,388,390,391).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [391]
In the citing paper
“A number of population-based studies have reported that certain groups of subjects with SH have increased fracture rates, including all adults (407), postmenopausal women (408), men (409), or subjects who progress to overt hyperthyroidism over time (391).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [391]
In the citing paper
“Sawin et al. (399) first reported a 2.8-fold increased risk of atrial fibrillation in SH subjects over age 60 years in 1994, and subsequent studies have confirmed that the risk of arrhythmias, particularly atrial fibrillation, is increased in SH (381,384,388,391,400,401).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [391]
In the citing paper
“Some of these studies re-ported increased risks of overall mortality in older subjects (380,429), cardiovascular events (391), heart failure (381), and atrial fibrillation in all subjects (401) or in older subjects (384), and vertebral fractures in older women (408).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [391]
Citations
Cites
The Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824
Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons
Sawin, C. T., Geller, A., Wolf, P. A., Belanger, A. J., Baker, E., Bacharach, P., Wilson, P., Benjamin, E. J., & D'Agostino, R. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311901 · Cited by 1,259
Thyroid Status, Disability and Cognitive Function, and Survival in Old Age
Gussekloo, J. (2004) · JAMA · doi:10.1001/jama.292.21.2591 · Cited by 899
Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults
Cappola, A. R., Fried, L. P., Arnold, A. M., Danese, M. D., Kuller, L. H., Burke, G. L., Tracy, R. P., & Ladenson, P. W. (2006) · JAMA · doi:10.1001/jama.295.9.1033 · Cited by 862
Parle, J. V., Maisonneuve, P., Sheppard, M. C., Boyle, P., & Franklyn, J. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06067-6 · Cited by 669
Subclinical thyroid dysfunction as a risk factor for cardiovascular disease
Walsh, J. P., Bremner, A. P., Bulsara, M. K., O’Leary, P., Leedman, P. J., Feddema, P., & Michelangeli, V. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2467 · Cited by 536
THE EPIDEMIOLOGY OF THYROID DISEASE AND IMPLICATIONS FOR SCREENING
Wang, C., & Crapo, L. M. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70240-1 · Cited by 520
Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality
Ochs, N., Auer, R., Bauer, D. C., Nanchen, D., Gussekloo, J., Cornuz, J., & Rodondi, N. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-11-200806030-00225 · Cited by 477
Faber, J., & Galløe, A. M. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1300350 · Cited by 377
Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study
Kalmijn, S., Mehta, K. M., Pols, H. A. P., Albert Hofman, D., Drexhage, H. A., & Breteler, M. M. B. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01146.x · Cited by 319
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–185 of 185
Burkauskas, J., Bunevičius, A., Brožaitienė, J., Neverauskas, J., Lang, P., Duwors, R., Mickuvienė, N., & Bunevičius, R. (2017) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acx004 · Cited by 11
Preoperative Subclinical Hyperthyroidism in Patients With Papillary Thyroid Carcinoma
Ahn, D., Sohn, J. H., Jeon, J., & Park, J. (2014) · Clinical and Experimental Otorhinolaryngology · doi:10.3342/ceo.2014.7.4.312 · Cited by 10
Association of Thyroid Hormone Medication Adherence With Risk of Dementia
Han, S., Jeong, S., Choi, S., Park, S. J., Kim, K. H., Lee, G., Cho, Y., Son, J. S., & Park, S. M. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad447 · Cited by 8
Long-term cardiovascular and cerebrovascular morbidity in Israeli thyroid cancer survivors
Izkhakov, E., Meyerovitch, J., Barchana, M., Shacham, Y., Stern, N., & Keinan‐Boker, L. (2019) · Endocrine Connections · doi:10.1530/ec-19-0038 · Cited by 10
Thyroid Hormones, Glucocorticoids, Insulin, and Bone
Lakatos, P. L., Szili, B., Bakos, B., Takács, I., Putz, Z., & Istenes, I. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_314 · Cited by 9
Thyroid dysfunction and risk of different types of dementia: A systematic review and meta-analysis
Ye, J., Huang, Z., Liang, C., Zhang, Y., Huang, L., Liu, Y., & Luo, Z. (2024) · Medicine · doi:10.1097/md.0000000000039394 · Cited by 8
Soto‐Pedre, E., Siddiqui, M. K., Mordi, I. R., Maroteau, C., Soto-Hernaez, J., Palmer, C. N. A., Pearson, E. R., & Leese, G. (2021) · European Thyroid Journal · doi:10.1159/000518058 · Cited by 8
Self-citationSubclinical Hyperthyroidism and Cardiovascular Risk
Palmeiro, C., Davila, M. I., Bhat, M., Frishman, W. H., & Weiss, I. A. (2013) · Cardiology in Review · doi:10.1097/crd.0b013e318294f6f1 · Cited by 7
Ge, Y., Xu, W., Tan, C., & Tan, L. (2020) · Aging · doi:10.18632/aging.103813 · Cited by 8
Radioiodine therapy of thyroid autonomy
Clerc, J. (2021) · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · doi:10.23736/s1824-4785.21.03340-9 · Cited by 7
Bladder Pain Syndrome/Interstitial Cystitis Is Associated with Hyperthyroidism
Chung, S., Liu, S., Lin, C.-C., Li, H.-C., & Lin, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072284 · Cited by 7
Subclinical hyperthyroidism and the risk of dementia: A meta‐analysis
Liu, Q., Lu, C., Chen, M., & Feng, P. (2024) · Brain and Behavior · doi:10.1002/brb3.70037 · Cited by 6
Delitala, A., Manzocco, M., Sinibaldi, F. G., & Fanciulli, G. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13254 · Cited by 6
Prevalencia e incidencia de los principales trastornos endocrinos y metabólicos
Liberman, G. C. (2013) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(13)70217-7 · Cited by 6
The Role of Thyroid Hormones in Neurodegenerative Disorders: Opportunities and Challenges
Zhang, Y., Hao, M., Li, Y., Cheng, K., & Zhang, C. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05290-w · Cited by 10
Higher serum free thyroxine levels are associated with increased risk of hip fractures in older men
Svensson, J., Ohlsson, C., Karlsson, M. K., Herlitz, H., Lorentzon, M., Lewerin, C., & Mellström, D. (2024) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjad005 · Cited by 5
Multidisciplinary approach to redefining thyroid hormone reference intervals with big data analysis
Lewis, C. W., Raizman, J. E., Higgins, V., Gifford, J. L., Symonds, C. J., Kline, G. A., Romney, J. S., Doulla, M., Huang, C., & Venner, A. A. (2024) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2024.110835 · Cited by 5
Thyrotropin and Alzheimer’s Disease Risk in the Elderly: a Systematic Review and Meta-Analysis
Wang, Y., Sheng, Q., Hou, X., Wang, B., Zhao, W., Yan, S., Wang, Y., & Zhao, S. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9078-x · Cited by 5
Thyroid Disorders and Bone Mineral Homeostasis
Feigerlová, E., Klein, M., Angelousi, A. G., Groza, L., Leheup, B., & Weryh, G. (2012) · InTech eBooks · doi:10.5772/46207 · Cited by 5
Erem, C., Civan, N., Coşkun, H., Menteşe, A., Suleyman, A. K., Altay, D. U., Akgul, Z., & Değer, O. (2015) · Clinical Endocrinology · doi:10.1111/cen.12955 · Cited by 5
Enfermedad tiroidea subclínica: revisión y enfoque clínico
Liberman, G. C. (2013) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(13)70219-0 · Cited by 7
Reyes‐García, R., Gimeno, E. J., Martín, A. G., Muñoz, M. R., Sáez, J. M. G., Fernández, I. L., Varsavsky, M., Iglesias, S. G., Rodríguez, I. C., Ballesteros-Pomar, M. D., et al. (2012) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2012.01.004 · Cited by 4
Skeletal Effects of Thyroid Hormones
Bakos, B., Takács, I., Stern, P. H., & Lakatos, P. L. (2018) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-018-9246-z · Cited by 4
Phowira, J., Bakhashab, S., Doddaballapur, A., & Weaver, J. U. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.894093 · Cited by 4
Karaca, Y., Karasu, M., Taşolar, H., & Evren, B. (2023) · Journal of Clinical Ultrasound · doi:10.1002/jcu.23459 · Cited by 4
NHG-Standaard Schildklieraando eningen (tweede herziening)
van Lieshout, J., Felix-Schollaart, B., Bolsius, E., de Boer, A. C. F. P., Burgers, J. S., Bouma, M., & Sijbom, M. (2013) · Cited by 4
Endogenous subclinical hyperthyroidism: who, when and why to treat
Biondi, B. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.69 · Cited by 4
Rajão, K. M. A. B., Ribeiro, A. L. P., Passos, V. M. D. A., Benseñor, I. M., Vidigal, P. G., Camacho, C. P., & Diniz, M. D. F. H. S. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190037 · Cited by 5
Gao, R., Lyu, X., Yang, Y., Fu, J., Zhao, C., Guan, H., & Ma, X. (2024) · Thyroid Research · doi:10.1186/s13044-024-00192-w · Cited by 3
Early detection of biochemically occult autonomous thyroid nodules
Brusca, N., Virili, C., Cellini, M., Capriello, S., Gargano, L., Salvatori, R., Centanni, M., & Santaguida, M. G. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0568 · Cited by 3
Joshi, M., Bisht, S., & Singh, M. F. (2019) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2019v11i10.34447 · Cited by 4
Impact of subclinical hyperthyroidism on bone
Koutroumpi, S., Stratigou, T., & Vlassopoulou, V. (2019) · Journal of Research and Practice on the Musculoskeletal System · doi:10.22540/jrpms-03-060 · Cited by 2
Cardiovascular system and endogenous subclinical hyperthyroidism treatment: The time has come
Patanè, S. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.04.145 · Cited by 2
Bergeron, Y., & Fyles, J. (2009) · Presses de l'Université du Québec eBooks · doi:10.1515/9782760523821-028 · Cited by 2
Thyroid Hormone in Bone and Joint Disorders
Bassett, J. H. D., & Williams, G. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804182-6.00031-9 · Cited by 2
Secondary and tertiary preventions of thyroid disease
Azizi, F., Mehran, L., Hosseinpanah, F., Delshad, H., & Amouzegar, A. (2018) · Endocrine Research · doi:10.1080/07435800.2018.1424720 · Cited by 3
Dischinger, U., & Faßnacht, M. (2018) · Der Internist · doi:10.1007/s00108-018-0441-2 · Cited by 2
The level of anxiety in women with graves’ disease
Ubaidullaeva, N. B., Allayarova, G. I., Nasyrkhodzhaev Ya, B., Si, I., Juraeva, N. A., & Almuradov, F. F. (2018) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2018.06.00227 · Cited by 2
Epidemiology of Thyroid Disease and Swelling
Vanderpump, M. P. J. (2022) · doi:10.1093/med/9780198870197.003.0045 · Cited by 2
Wass, J. A. H., Owen, K. R., & Turner, H. E. (2014) · Oxford University Press eBooks · doi:10.1093/med/9780199644438.003.0001 · Cited by 2
Endothelial dysfunction in subclinical hyperthyroidism: a randomised trial
Shakoor, S. A. K. K. A., Jiao, H., Ong, K. H., Tan, A., & Liew, H. (2021) · Singapore Medical Journal · doi:10.11622/smedj.2021215 · Cited by 1
Features of cognitive impairment in patients with thyroid dysfunction
Romashevsky, B. V., Салухов, В. В., & Maksim, O. V. (2023) · Bulletin of the Russian Military Medical Academy · doi:10.17816/brmma492328 · Cited by 1
Higher thyroid hormone levels and cancer
Ovčariček, P. P., Campennì, A., Ruggeri, R. M., Kreissl, M. C., Verburg, F. A., Vrachimis, A., Tuncel, M., & Giovanella, L. (2024) · Vitamins and hormones · doi:10.1016/bs.vh.2024.08.002 · Cited by 1
Fujisawa, C., Fujisawa, H., Matsui, Y., Sugimoto, T., Minakami, M., Watanabe, K., Yamada, Y., Nakashima, H., Komiya, H., Sugimura, Y., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261424207 · Cited by 1
The clinical impact of thyroid epidemiology
Leese, G., & Flynn, R. W. V. (2012) · Clinical Medicine · doi:10.7861/clinmedicine.12-6-s64 · Cited by 1
Self-citationMetabolism and mineral one density in thyrotoxicosis (literature review)
Shymon, V. M., & Stojka, V. (2017) · ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS · doi:10.15674/0030-598720171113-117 · Cited by 1
Thyroid Disorders and Osteoporosis
Ale, A. O. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.87129 · Cited by 1
Pearce, S. H. S. (2022) · doi:10.1093/med/9780198870197.003.0057 · Cited by 1
An Overview of Endogenous Subclinical Hyperthyroidism and Cardiac Disease
Woeber, K. A. (2016) · Endocrine Practice · doi:10.4158/ep161437.co · Cited by 1
Вплив хвороби Грейвса на психокогнітивний стан дітей і дорослих (огляд літератури)
Муратова, Ш. Т., & Ismailov, S. I. (2016) · INTERNATIONAL NEUROLOGICAL JOURNAL · doi:10.22141/2224-0713.5.83.2016.78483 · Cited by 1
Shakoor, S. A. K. K. A., Jiao, H. L., Tan, A. W. K., & Huiling, L. (2021) · Journal of Endocrinology and Metabolism · doi:10.14740/jem723 · Cited by 1
El hueso en el hipertiroidismo
Gimeno, E. J., & Berdonces, M. C. (2014) · Elsevier eBooks · doi:10.1016/b978-84-9022-503-5.00006-x
Osteoporosis secundaria. tratamiento actualizado
Oviedo, G. S. (2013) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(13)70227-x
Jd, H., Leiva, P., Ml, M. D. P., & Juan, S. (2012)
Actual, E., Antonia, D., & Despaigne, N. (2015)
Iperfunzione tiroidea nell’anziano
Pasqualetti, G., Ilacqua, A., Niccolai, F., Belfiore, A., & Monzani, F. (2016) · L Endocrinologo · doi:10.1007/s40619-016-0232-8
Влияние болезни Грейвса на психокогнитивное состояние детей и взрослых (обзор литературы)
Муратова, Ш. Т., & Ismailov, S. I. (2016) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.6.70.2015.72645
Hormonas tiroideas, TSH, cáncer de tiroides y hueso en mujeres pre y postmenopáusicas
Carranza, F. H., Iglesias, S. G., Diaz‐Guerra, G. M., Álvarez, B., & Domínguez, M. D. M. (2017) · Revista de Osteoporosis y Metabolismo Mineral · doi:10.4321/s1889-836x2017000200006 · Cited by 1
The importance of assessing the cognitive status of patients in the general medicine practice
Kostić, M., Radosavljević, O., & Vučković, M. (2018) · Opšta medicina · doi:10.5937/opmed1801033k
Soeiro, A. D. M. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190102
Dischinger, U., & Faßnacht, M. (2018) · Der Internist
Thyroid Function and Effects on Cardiovascular System
Berra, C., & Barrasso, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-80267-7_13
Management of Non-Toxic Multinodular Goitre
Graf, H., & Paz-Filho, G. (2022) · doi:10.1093/med/9780198870197.003.0075
Brenta, G., & Sgarbi, J. A. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_24
Alves, M. L. D. (2021) · Japan Journal of Research · doi:10.33425/2690-8077.1032
Martins, J. M., Reis, D., Batista, L., Paramés, F., de Almeida, M. M., & Cantinho, G. (2019) · Journal of Endocrinology and Metabolism · doi:10.14740/jem550
Hassan, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-25871-3_10
Proust-Lemoine, E., & Wémeau, J.-L. (2018) · EMC - AKOS - Trattato di Medicina · doi:10.1016/s1634-7358(18)91702-x
Dharmalingam, M., & Bobba, R. (2020) · APIK Journal of Internal Medicine · doi:10.4103/ajim.ajim_21_20
Proust-Lemoine, E., & Wémeau, J.-L. (2018) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(18)91423-6
Мінеральна щільність та метаболізм кісткової тканини у разі тиреотоксикозу
Стойка, В. В. (2022) · Науковий вісник Ужгородського університету Серія Медицина · doi:10.32782/2415-8127.2022.65.8
Ahmed, E. A., Soliman, A. T., & Farag, M. M. (2022) · Alexandria Journal of Pediatrics · doi:10.4103/ajop.ajop_31_22
Ursem, S. R., Noordam, R., van den Berg, J. M., Boelen, A., Elders, P. J. M., den Elzen, W. P. J., & Heijboer, A. C. (2025) · Thyroid · doi:10.1177/10507256261449444
Kim, J.-W., Bae, H., Moon, J. S., & Kim, S.-W. (2025) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2025.14.2.236
Svensson, J., Ohlsson, C., Karlsson, M. K., Tivesten, Å., Herlitz, H., Lorentzon, M., Lewerin, C., & Mellström, D. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf121
Thyroid Dysfunction, Metabolic Syndrome, and Cardiovascular Risk
Massarini, S., & Luzi, L. (2025) · Springer eBooks · doi:10.1007/978-3-032-01700-0_1
Gao, R., Lyu, X., Yang, Y., Fu, J., Zhao, C., Guan, H., & Ma, X. (2024) · Figshare · doi:10.6084/m9.figshare.25378195
Gao, R., Lyu, X., Yang, Y., Fu, J., Zhao, C., Guan, H., & Ma, X. (2024) · Figshare · doi:10.6084/m9.figshare.25378040
Gao, R., Lyu, X., Yang, Y., Fu, J., Zhao, C., Guan, H., & Ma, X. (2024) · Figshare · doi:10.6084/m9.figshare.26684856
Gao, R., Lyu, X., Yang, Y., Fu, J., Zhao, C., Guan, H., & Ma, X. (2024) · Figshare · doi:10.6084/m9.figshare.26684853
Alsifri, S., Khader, S., Alzahrani, A., Almehthel, M., Almansari, A., Alhozali, A. M., Aljuhani, N. R., Jammah, A. A., Farahat, R., Elbadawi, H., et al. (2025) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2025.169025
Lab Work Relevant for Cognitive Functioning
Sheppard, D. P., Pagulayan, K. F., Hendrickson, R., & Parmenter, B. A. (2026) · Oxford University Press eBooks · doi:10.1093/9780197619537.003.0010
Karatepe, B. A., Çil, B. Ö., Karagöz, Z. K., Altun, G., & Hoşgün, D. (2026) · BMC Pulmonary Medicine · doi:10.1186/s12890-026-04590-8
The Underdiagnosed Endocrinopathy: Subclinical Hyperthyroidism and Its Burden in Older Adults
Garg, R. (2026) · South Asian Journal of Geriatric Medicine Surgery Palliative Care & Hospice · doi:10.4103/sajogm.sajogm_27_26
Metadata
- Authors
- Vadiveloo, T., Donnan, P. T., Cochrane, L., & Leese, G. P.
- Affiliations
- University of Dundee (GB)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-05
- Volume
- 96
- Issue
- 5
- Pages
- 1344-1351
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2163166383
- Cited by
- 186
- References
- 20
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 14 · 2023: 7 · 2022: 8 · 2021: 11 · 2020: 12 · 2019: 17 · 2018: 14 · 2017: 14 · 2016: 19 · 2015: 11 · 2014: 10 · 2013: 12 · 2012: 21
- FWCI
- 12.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- Funders
- GlaxoSmithKline
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- subclinical hyperthyroidism, cardiovascular morbidity, cardiac arrhythmias, osteoporotic fractures, dementia, cancer risk, overt hyperthyroidism, thyroid-stimulating hormone, long-term outcomes, thyroid dysfunction
- MeSH terms
- Age Factors, Aged, Arrhythmias, Cardiac, Cardiovascular Diseases, Dementia, Female, Follow-Up Studies, Humans, Hyperthyroidism, Male, Middle Aged, Neoplasms, Osteoporosis, Scotland, Sex Factors, Thyroid Hormones, Thyrotropin, Databases, Factual, Treatment Outcome, Risk Assessment, Fractures, Bone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
